Baishen Zhang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Efficacy and safety with aumolertinib plus anlotinib for untreated EGFR-mutant NSCLC with brain metastases.
Journal: NPJ precision oncology
Published: July 21, 2025
A multimodal synergistic model for personalized neoadjuvant immunochemotherapy in esophageal cancer.
A multimodal synergistic model for personalized neoadjuvant immunochemotherapy in esophageal cancer.
Journal: Cell reports. Medicine
Published: July 15, 2025
Linoleic acid drives pulmonary lymphoepithelioma-like carcinoma progression via PPAR-α/TF axis.
Journal: Frontiers in oncology
Published: June 19, 2025
Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis.
Journal: Translational lung cancer research
Published: April 15, 2024
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases.
Journal: Oncoimmunology
Published: January 03, 2024
Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first-line treatment of unresectable thymic carcinoma: A multicenter retrospective study.
Journal: International journal of cancer
Published: December 19, 2023
Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer.
Journal: Journal of inflammation research
Published: November 21, 2023
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 Study.
Journal: JAMA network open
Published: February 08, 2023
Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
Journal: BMC medicine
Published: January 08, 2023
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
Journal: BMC medicine
Published: April 13, 2022
Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study.
Journal: Journal of cancer research and clinical oncology
Published: November 23, 2021
ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 23, 2021
Last Updated: 09/26/2026